CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
ESGYX
Price
$21.94
Change
-$0.16 (-0.72%)
Updated
Jul 13 closing price
Net Assets
658.86M
Interact to see
Advertisement

CNPAX vs ESGYX

CNPAX vs ESGYX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. ESGYX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and ESGYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. ESGYX (659M). CNPAX pays higher dividends than ESGYX: CNPAX (0.95) vs ESGYX (0.37). CNPAX was incepted earlier than ESGYX: CNPAX (24 years) vs ESGYX (10 years). ESGYX (1.01) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. ESGYX (21.00). CNPAX has a lower initial minimum investment than ESGYX: CNPAX (250) vs ESGYX (100000). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. ESGYX (3.19). CNPAX return over 5 years is better than : 13.82 vs. ESGYX (2.24).
CNPAXESGYXCNPAX / ESGYX
Total Expense Ratio0.740.9578%
Annual Report Gross Expense Ratio0.741.0173%
Fund Existence24 years10 years-
Gain YTD5.325-0.724-735%
Front Load4%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets170B659M25,797%
Annual Yield % from dividends0.950.37261%
Returns for 1 year7.373.19231%
Returns for 3 years34.1724.37140%
Returns for 5 years13.822.24618%
Returns for 10 years115.91120.6496%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6